Health Care Sector Stocks Coverage -- Research on RadNet, IMS Health Holdings, WuXi PharmaTech Cayman, and Ventrus Biosciences

LONDON, June 18, 2014 /PRNewswire/ --

On Tuesday, June 17, 2014, the NASDAQ Composite ended at 4,337.23, up 0.37%, the Dow Jones Industrial Average finished the day 0.16% higher at 16,808.49, and the S&P 500 closed at 1,941.99, up 0.22%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 688.85, down 0.07%, while the index has advanced 2.52% in the last one month. Investor-Edge has initiated coverage on the following equities: RadNet Inc. (NASDAQ: RDNT), IMS Health Holdings Inc. (NYSE: IMS), WuXi PharmaTech Cayman Inc. (NYSE: WX) and Ventrus Biosciences Inc. (NASDAQ: VTUS). Free technical research on RDNT, IMS, WX and VTUS can be downloaded upon signing up at:

http://www.investor-edge.com/3916-register

On Tuesday, RadNet Inc.'s stock recorded a trading volume of 0.39 million shares, lower than its three months average volume of 0.81 million shares. The stock finished the day at $7.15, down 1.38%, and registered an intraday range of $7.12 and $7.40. RadNet Inc.'s shares have rallied 19.97% in the last one month and 160.00% in the previous three months. Also, the stock has surged 328.14% on YTD basis. Furthermore, the company's stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $5.65 is above its 200-day moving average of $3.06. Additionally, shares of the company traded at a PE ratio of 242.73 and have a Relative Strength Index (RSI) of 68.35. Sign up today to read free research on RDNT at:

http://www.investor-edge.com/3916-RDNT-18Jun2014.pdf

IMS Health Holdings Inc.'s stock fell by 0.13%, to close Tuesday's session at $23.80, after oscillating between $23.57 and $24.27. The stock recorded a trading volume of 1.21 million shares during the session. Over the past three trading sessions, IMS Health Holdings Inc.'s shares have fallen by 2.58%. However, over the last one month, the company's stock has gained 2.50%. The stock is trading below its 50-day moving average of $23.96. Further, the company's stock has an RSI of 47.55. Sign up today to read free research on IMS at:

http://www.investor-edge.com/3916-IMS-18Jun2014.pdf

Shares in WuXi PharmaTech Cayman Inc. fluctuated between $30.65 and $31.95 before ending Tuesday's session down 0.87%, at $30.69. The company's stock reported a trading volume of 0.72 million shares, below its three months average volume of 0.54 million shares. Further, shares of WuXi PharmaTech Cayman Inc. have declined 6.38% over the last one month and 18.42% over the past three months. Also, the stock has lost 20.04% on YTD basis. The stock is trading below its 50-day and 200-day moving averages. The stock's 50-day moving average of $34.34 is greater than its 200-day moving average of $33.34. Moreover, shares of the company traded at a PE ratio of 22.08 and have an RSI of 34.06. Sign up today to read free research on WX at:

http://www.investor-edge.com/3916-WX-18Jun2014.pdf

On Tuesday, Ventrus Biosciences Inc.'s stock finished the session 3.65% higher at $1.42. A total of 0.77 million shares were traded, which was above its three months average volume of 0.70 million shares. The stock moved between $1.28 and $1.45 during the session. Over the past three trading sessions and since the start of this year, Ventrus Biosciences Inc.'s shares have fallen by 9.55% and 62.83%, respectively. However, the stock has gone up 33.96% over the last one month. The company's shares are trading above their 50-day moving average. Moreover, the stock's 200-day moving average of $2.37 is greater than its 50-day moving average of $1.13. Shares of Ventrus Biosciences Inc. have an RSI of 57.26. Sign up today to read free research on VTUS at:

http://www.investor-edge.com/3916-VTUS-18Jun2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com .

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com .

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED